.
Cardiology (Pathology Clinical Pharmacology Methods of Examination and Interpretation of Data, Symptomatology and Pharmacotherapy)
Study Course Description
Course Description Statuss:Approved
Course Description Version:4.00
Study Course Accepted:21.03.2024 09:18:28
| Study Course Information | |||||||||
| Course Code: | ISK_014 | LQF level: | Level 7 | ||||||
| Credit Points: | 3.00 | ECTS: | 4.50 | ||||||
| Branch of Science: | Basic Sciences of Medicine, including Pharmacy; Clinical Pharmacy | Target Audience: | Clinical Pharmacy | ||||||
| Study Course Supervisor | |||||||||
| Course Supervisor: | Larisa Umnova | ||||||||
| Study Course Implementer | |||||||||
| Structural Unit: | Department of Internal Diseases | ||||||||
| The Head of Structural Unit: | |||||||||
| Contacts: | Riga, 2 Hipokrata Street, isk rsu[pnkts]lv, +371 67042338 | ||||||||
| Study Course Planning | |||||||||
| Full-Time - Semester No.1 | |||||||||
| Lectures (count) | 8 | Lecture Length (academic hours) | 3 | Total Contact Hours of Lectures | 24 | ||||
| Classes (count) | 6 | Class Length (academic hours) | 2 | Total Contact Hours of Classes | 12 | ||||
| Total Contact Hours | 36 | ||||||||
| Study course description | |||||||||
| Preliminary Knowledge: | Human anatomy, physiology and pathology, medical biochemistry, pharmacology. | ||||||||
| Objective: | To provide students with knowledge in clinical areas – pathophysiology of cardiovascular diseases, clinical manifestations, evaluation of examinations, basic methods of treatment and pharmacotherapy options for cardiovascular diseases. The study module comprises an integrated training cycle in which the student is gradually introduced to the pathological physiology of a group of diseases, clinical pharmacology, clinical manifestations, examination possibilities, interpretation of examination data, principles of treatment and pharmacotherapy possibilities. | ||||||||
| Topic Layout (Full-Time) | |||||||||
| No. | Topic | Type of Implementation | Number | Venue | |||||
| 1 | Pathological physiology of the cardiovascular system. | Lectures | 1.00 | auditorium | |||||
| 2 | Structure and functions of the cardiovascular system. | Lectures | 1.00 | auditorium | |||||
| 3 | Pathological cardiovascular physiology. | Classes | 1.00 | auditorium | |||||
| 4 | Clinical pharmacology in cardiology. | Lectures | 2.00 | auditorium | |||||
| 5 | Pharmacological agents for the treatment of cardiovascular diseases. | Classes | 1.00 | auditorium | |||||
| 6 | Complaints and anamnesis in patients with cardiovascular diseases. Cardiovascular risk factors. Physical examination of the patient. Examination methods in cardiology. Fundamentals of electrocardiography. Principles and role of echocardiography in the assessment of cardiovascular structure and function. Indications and diagnostic value of cardiac computed tomography and magnetic resonance imaging. | Lectures | 1.00 | clinical base | |||||
| 7 | Arterial hypertension. Primary and secondary arterial hypertension. Risk factors, clinical manifestations, target organ damage, complications of hypertension. Non-pharmacological and pharmacological treatment of arterial hypertension. | Lectures | 1.00 | clinical base | |||||
| 8 | Atherosclerosis: epidemiology, risk factors, examinations required and principles of therapy. Coronary heart disease: epidemiology, risk factors, clinical manifestations, patient examination options. Stable angina pectoris. Acute coronary syndrome. Unstable angina. Myocardial infarction. | Lectures | 1.00 | clinical base | |||||
| 9 | The concept of cardiac arrhythmias. Classification of arrhythmias, causes, pathogenesis, diagnostic principles. Principles of treatment of arrhythmias. Life-threatening arrhythmias. Acute and chronic heart failure: classification, causes, pathophysiological mechanisms, clinical manifestations, diagnosis and treatment principles. | Lectures | 1.00 | clinical base | |||||
| 10 | Individual and combined treatment of arterial hypertension. Hypertensive crisis: types, treatment principles and tactics. | Classes | 1.00 | clinical base | |||||
| 11 | Coronary heart disease. Acute coronary syndrome, causes thereof. Acute coronary syndrome without ST elevation. ACS with ST elevation. Myocardial infarction: mechanisms, clinical manifestations, complications, treatment principles and tactics. Chronic coronary disease: types, diagnostic methods and treatment principles. | Classes | 1.00 | clinical base | |||||
| 12 | Inflammatory heart diseases: main types, principles of diagnosis and treatment. Pulmonary artery thromboembolism. Valvular heart disease: epidemiology, causes, diagnosis and treatment options. Principles of surgical treatment of valvular heart disease. | Classes | 1.00 | clinical base | |||||
| 13 | Clinical assessment and basic principles of treatment in case of acute and chronic heart failure. Pharmacological and non-pharmacological treatment of arrhythmias. | Classes | 1.00 | clinical base | |||||
| Assessment | |||||||||
| Unaided Work: | The student independently studies the literature offered in the study programme, summarises the obtained information. Prepares a clinical pharmacist’s assessment in cases of pharmacotherapy for patients with cardiovascular diseases. | ||||||||
| Assessment Criteria: | Active participation in practical classes; written assignments completed in high quality and submitted on time, quality of oral answers. Test: understanding of the principles of diagnosis and treatment of cardiological diseases, including clinical case analysis, is tested. | ||||||||
| Final Examination (Full-Time): | Exam | ||||||||
| Final Examination (Part-Time): | |||||||||
| Learning Outcomes | |||||||||
| Knowledge: | As a result of successfully completing the course, the student will have knowledge of the following: • mechanisms of origin of cardiovascular diseases; • the most common clinical manifestations and complications of cardiovascular diseases; • cardiovascular disease examination options; • basic types of treatment of cardiovascular diseases; • pharmacotherapy options for cardiovascular diseases. | ||||||||
| Skills: | The student will be able: • to interpret cardiovascular system examination results; • to assess pharmacotherapy for cardiovascular diseases. | ||||||||
| Competencies: | The student will be able: • in collaboration with the medical practitioners, to determine a pharmacotherapy plan for an individual patient with a cardiovascular disease; • to assess the advantages and disadvantages of pharmacotherapy methods in relation to the patient’s examination data; • to monitor the progress of pharmacotherapy, predict side effects and plan the prevention thereof, and provide the necessary information to other medical specialists. | ||||||||
| Bibliography | |||||||||
| No. | Reference | ||||||||
| Required Reading | |||||||||
| 1 | Braunwalds Heart Disease: A textbook of cardiovascular medicine, 12th ed., WB Saunders, 2022 | ||||||||
| 2 | Ērglis A., Jēgere S., Kalējs O., Kalvelis A., Kamzola G., Lācis J., Mača A., Mintāle I., Narbute I., Stradiņš P., Zakke I. Hroniskas sirds mazspējas klīniskās vadlīnijas. Rīga, Latvijas Kardiologu biedrība, 2013 | ||||||||
| 3 | Ērglis A., Kalvelis A., Latkovskis G., Zakke I., Jēgere S., Mača A., Narbute I., Trušinskis K., Ratobiļska S. Akūta koronāra sindroma AKS diagnostikas, loģistikas un ārstēšanas vadlīnijas. Rīga, Latvijas Kardiologu biedrība, 2011 (akceptējams izdevums) | ||||||||
| 4 | Ērglis A., Kalvelis A., Lejnieks A., Dzērve V., Latkovskis G., Mintāle I., Zakke I., Rasa I. Kardiovaskulāro slimību KVS profilakses vadlīnijas. Latvijas Kardioloģu biedrība, Rīga, 2007 (akceptējams izdevums) | ||||||||
| 5 | 2013 ESH/ESC Guidelines for the management of arterial hypertension. European Heart Journal, doi:10.1093/eurheartj/eht151 | ||||||||
| 6 | A. Lejnieka red. Klīniskā medicīna. Pirmā grāmata. Rīga, Medicīnas apgāds, 2010 (akceptējams izdevums) | ||||||||
| 7 | Lekciju un nodarbību materiāli. | ||||||||
| Additional Reading | |||||||||
| 1 | 2013 ESC guidelines on the management of stable coronary artery disease. European Heart Journal (2013) 34, 2949–3003 doi:10.1093/eurheartj/eht296 | ||||||||
| 2 | Lüscher T., Ed. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. http://dx.doi.org/10.1093/eurheartj/eht108 | ||||||||
| 3 | The Merck Manual of diagnosis and therapy, edited by Robert S.Porter, 20th ed., 2018 | ||||||||
| 4 | Siegenthaler W. Differential Diagnosis in Internal medicine: From Symptom to Diagnosis. NY: Thieme Medical Publishers, 2007 | ||||||||
| Other Information Sources | |||||||||
| 1 | The Merck Manual, Internets | ||||||||
| 2 | http://www.merck.com/mrkshared/manual/home.jsp | ||||||||
| 3 | Universal definition of myocardial infarction. Expert Consenus Document. Eur. H.J., 2007; 28: 2525-2538. | ||||||||
| 4 | Valvular Heart Disease. ESC Guidelines. Eur. H.J., 2007; 28: 230-268. | ||||||||
| 5 | Welsby P.D. Clinical history taking and examination. 2nd edition. London: Churchill Livingstone, 2002 | ||||||||
